AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,097,000 | +20.3% | 16,261 | +0.9% | 0.03% | +18.5% |
| Q1 2021 | $912,000 | -34.1% | 16,115 | -5.1% | 0.03% | -38.6% |
| Q4 2020 | $1,383,000 | +157.1% | 16,980 | +125.0% | 0.04% | +120.0% |
| Q3 2020 | $538,000 | -13.4% | 7,547 | 0.0% | 0.02% | -16.7% |
| Q2 2020 | $621,000 | +2.3% | 7,547 | -26.8% | 0.02% | -14.3% |
| Q1 2020 | $607,000 | -74.8% | 10,312 | -55.8% | 0.03% | -65.0% |
| Q4 2019 | $2,412,000 | – | 23,339 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |